Trends and analysis of risk factor differences in the global burden of chronic kidney disease due to type 2 diabetes from 1990 to 2021: A population‐based study

CKD-T2D imposes a significant global disease burden, with health disparities and unequal disease outcomes continuing to worsen across countries and regions due to differences in socio-economic development levels. This burden is primarily driven by population growth, ageing and metabolic risks such as obesity, hyperglycaemia and hypertension. Although the rate of increase in disease burden may slow over the next 15 years, the number of cases is expected to rise substantially. Therefore, enhancing prevention, early screening and effective treatment interventions, particularly in high-risk areas, is crucial for reducing the disease burden and narrowing health disparities.